Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea1

Kantele, Anu; Mero, Sointu; Kirveskari, Juha; Lääveri, Tinja

doi:10.3201/eid2201.151272

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea1

Published Date:

Jan 2016

Publisher's site:

http://dx.doi.org/10.3201/eid2201.151272 New Site Icon

Source:

Emerg Infect Dis. 22(1):117-120.

[PDF - 465.29 KB]

Details:

Personal Authors:

Kantele, Anu ; Mero, Sointu ; Kirveskari, Juha ; Lääveri, Tinja ;

Keywords:

[+]

Pubmed ID:

26691898

Pubmed Central ID:

PMC4696706

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Description:

Antimicrobial drug treatment of travelers' diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers' diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the rate was 20%; with antimicrobial drugs alone, 40%; and with loperamide and antimicrobial drugs, 71%.

Supporting Files:

15-1272-F.gif	image/gif
15-1272-F.jpg	image/jpeg
15-1272.nxml	application/octet-stream
license.txt	text/plain

You May Also Like: